Anthem Biosciences Pvt. Ltd, No. 49, Bommasandra Industrial Area, Bommasandra, Bangalore 560099, Karnataka, India.
Eur J Med Chem. 2011 Jun;46(6):2503-12. doi: 10.1016/j.ejmech.2011.03.039. Epub 2011 Apr 13.
Three new series of quinoline-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines were synthesized through multi-step reactions. The required intermediate, [1-(6-methoxy-2-methylquinolin-4-yl)-1H-1,2,3-triazol-4-yl]methanol (2) was prepared by treating 4-azido-6-methoxy-2-methylquinoline (1) with propargyl alcohol. Three different series of compounds were synthesized from this intermediate. All the newly synthesized compounds were characterized by spectral and elemental analyses. The structure of 2 was confirmed by X-ray crystallographic study. Further, the title compounds were evaluated for their in vitro anti-bacterial activity against five different bacterial strains and antimycobacterial activity against Mycobacterium tuberculosis H37Rv, Mycobacterium smegmatis (ATCC 19420) and Mycobacterium fortuitum (ATCC 19542). Title compounds, 6a, 6d, 6i, 6j, 7e, 10a and 10i were found to be active against Mycobacterium tuberculosis H37Rv strain and could be lead molecules of interest.
通过多步反应合成了三个新的含酰胺、磺酰胺和氨甲酰哌嗪的喹啉-4-基-1,2,3-三唑系列。所需的中间体[1-(6-甲氧基-2-甲基喹啉-4-基)-1H-1,2,3-三唑-4-基]甲醇(2)是通过将 4-叠氮基-6-甲氧基-2-甲基喹啉(1)与丙炔醇反应制得的。从该中间体合成了三个不同系列的化合物。所有新合成的化合物均通过光谱和元素分析进行了表征。通过 X 射线晶体学研究证实了 2 的结构。此外,还评估了标题化合物对五种不同细菌菌株的体外抗菌活性和对结核分枝杆菌 H37Rv、耻垢分枝杆菌(ATCC 19420)和偶发分枝杆菌(ATCC 19542)的抗分枝杆菌活性。标题化合物 6a、6d、6i、6j、7e、10a 和 10i 对结核分枝杆菌 H37Rv 菌株具有活性,可能是有前途的先导化合物。